Ypsomed Holding AG (YPSN.SW) stock: key figures, P/E, revenue and dividend
Health Care · Switzerland · ISIN CH0019396990
Ypsomed Holding AG financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 748.87 m CHF | 730.98 m CHF |
| Gross profit | 292.07 m CHF | 314.61 m CHF |
| Operating income | 112.85 m CHF | 246.08 m CHF |
| Net income | 87.50 m CHF | 221.93 m CHF |
| Diluted EPS – continuing operations | 6.41 CHF | 16.30 CHF |
Full history since 2002, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
More stocks
- ConvaTec Group PLC (CTEC.L)
- Eldorado Gold Corp (ELD.TO)
- Shenzhen Sunway Communication (300136.SZ)
- Atco Ltd (ACO.X.TO)
- Vipshop Holdings Ltd (VIPS)
- MAXLINEAR, INC (MXL)
- BBB Foods Inc. (TBBB)
- Shenzhen Kedali Industry Co Ltd (002850.SZ)
- Land Securities Group PLC (LAND.L)
- Haidilao International Holding Ltd (6862.HK)
- Airtac International Group (1590.TW)
- Weatherford International plc (WFRD)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.